Prostate Cancer

Summary of recommendations for clinicians and policy-makers

This clinical practice guideline applies to all men not previously diagnosed with prostate cancer. This includes men with lower urinary tract symptoms (nocturia, urgency, frequency and poor stream) or with benign prostatic hyperplasia (BPH). The CTFPHC will continue to carefully monitor the scientific development in prostate cancer screening and report back to Canadians within 5 years with an update of the 2014 Prostate Cancer Screening guideline.

Recommendations

• For men aged less than 55 years, we recommend not screening for prostate cancer with the prostate-specific antigen test.
  (Strong recommendation; low quality evidence)
• For men aged 55–69 years, we recommend not screening for prostate cancer with the prostate-specific antigen test.
  (Weak recommendation; moderate quality evidence)
• For men 70 years of age and older, we recommend not screening for prostate cancer with the prostate-specific antigen test.
  (Strong recommendation; low quality evidence)